Gastrointestinal stromal tumors: a case report

Advances in the identification of gastrointestinal stromal tumors, its molecular and immunohiostochemical basis, and its management have been a watershed in the treatment of gastrointestinal tumors. This paradigm shift occurred over the last two decades and gastrointestinal stromal tumors have now come to be understood as rare gastrointestinal tract tumors with predictable behavior and outcome, replacing the older terminologies like leiomyoma, schwannoma or leiomyosarcoma. This report presents a case of gastric gastrointestinal stromal tumor operated recently in a 47-year-old female patient and the outcome, as well as literature review of the pathological identification, sites of origin, and factors predicting its behavior, prognosis and treatment.

Single photon emission computed tomography of technetium 99m tetrofosmin myocradial perfusion imaging in patients with sytemic lupus erythematosus: a preliminary report

This study was to evaluate the utility of single-photon emission computed tomography [SPECT] of Technetium 99m tetrofosmin [Tc-99m TF] myocardial perfusion imaging to detect myocardial involvement in patients with systemic lupus erythematosus [SLE] Three groups of subjects-group 1: 25 SLE female patients with non-specific cardiac symptoms and signs, group 2: 25 female SLE patients without any cardiac symptoms and signs, and group 3: 25 female healthy controls-were evaluated by comparing rest and dipyridamole-stress Tc-99m TF myocardia] perfusion SPECT. Tc-99m TF myocardial perfusion SPECT revealed perfusion defects in 88% and 40% of the cases in groups 1 and 2, respectively. However, no cases in group 3 demonstrated myocardial perfusion defects. Tc-99m TP myocardial perfusion SPECT is a useful noninvasive imaging modality to detect cardiac involvement in SLE patients with or without cardiac symptoms and signs

Relation between cardiomyopathy and exercise capacity multicenter trial

The six-minute walk test [6MW lest] is a safe and simple method to assess exercise capacity in patients with left ventricular [LV] dysfunction. Recent studies confirmed its prognostic significance. The aim of this Study: Was to identify determinants of exercise capacity in patients with LV dysfunction as assessed by 6MW test. and 116 Patients with LV dysfunction caused by ischemic heart disease or idiopathic dilated cardiomyopathy [NYHA class l-IIl] underwent 6MW test, M-mode, two dimensional and Doppler transthoracic echocardiographic studies. 115 Patients were able to perform the 6MW test. The mean distance walked was 277 +/- 114m. Univariate analysis revealed that heart rate, systolic and diastolic arterial pressures, NYHA class, left atrial size, LV myocardial mass index, end-systolic and end-diastolic volume indices, ejection fraction, isovolumic relaxation time, peak early [PE] and peak atrial [PA] wave velocities of LV diastolic filling, PE/PA ratio and deceleration nine of early filling were all significantly related lo 6MW test distance [p<0.05]. Multivariate step-wise regression analysis showed that the only independent determinants of 6 MW test distance were PA wave velocity [F to enter 192.71, multiple r=0.79], PE/PA ratio [F to enter 115.22, multiple r=-0.37], and heart rate [F to enter 80.98, multiple r=-0.12]. Doppler-derived indices of LV diastolic function [PA wave velocity and PE/PA ratio] and heart rate are the main determinants of exercise capacity in patients with LV dysfunction as assessed by 6MW test

Early change of thyroid hormone concentration after 131I treatment in patients with solitary toxic noudule

In spite of extensive use of 131I for treatment hyperthyroidism, the results of early outcome are variable. To test whether 131 I induced necrosis causing clinical aggravation of hyperthyroidism and increasing the free thyroid Hormone concentration in the serum of patients with solitary nodule not pretreated with antithyroid drugs. Thirty consecutive patients were treated with 925 MBq 131 I. Serum concentration of thyrotropin [SH] free thyroxine [fT4], free triiodothyronine [fT3], Thyroglobuline [Tg], and interleukin-6 [IL-6] were measured A'lure and after application of 131 I. After application of 131 I no clinical worsening I was observed. FT4 and fT3 concentration did not change significantly within the first five days, whereas both of them significantly decreased after 12 days [p<0.0001]. Slight and clinically irrelevant increase in the level of the two thyroid innones was observed in 9 patients. Furthermore, we observed a prolonged increase in Tg concentration and a transient [iirrease in IL-6 concentration. Neither evidence of any clinical aggravation hyperthyroidism nor any significant increase in thyroid inrmone concentration by 131 I induced necrosis of thyroid cells was found. Therefore, the application of 131 I may be concidered as a safe and effective treatment for patients with typerthyroidism due to toxic adenoma.